Effects of natural products on the function of human organic anion transporting polypeptide 1B1

Xenobiotica

Volumn 42, Issue 4, 2012, Pages 339-348

  Wu, Lan Xiang ^a   Guo, Cheng Xian ^b   Qu, Qiang ^b   Yu, Jing ^b   Chen, Wang Qing ^b   Wang, Guo ^b   Fan, Lan ^b   Li, Qing ^b   Zhang, Wei ^b   Zhou, Hong Hao ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Drug transporter; natural productdrug interactions; pharmacokinetics

Indexed keywords

ANION TRANSPORT POLYPEPTIDE 1B1; ANION TRANSPORT PROTEIN; ARTEMISIN; ASTRAGALOSIDE IV; AURANTIIN; BAICALEIN; COLCHICINE; COUMARIN; CYTOCHROME P450; ESTRONE SULFATE; EVODIAMINE; GENIPOSIDE; GENISTEIN; GINSENOSIDE RC; GLYCYRRHIZIC ACID; GYPENOSIDE; HESPERETIN; HYPERIN; ICARIIN; ISOQUERCITRIN; NATURAL PRODUCT; NOBILETIN; PEONOL; POLYDATIN; QUERCETIN; RUTOSIDE; SCHIZANDROL A; SENNOSIDE B; SYRINGIN; UNCLASSIFIED DRUG; WOGONOSIDE;

ANION TRANSPORT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IC 50; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BIOLOGICAL AGENTS; BIOLOGICAL TRANSPORT; ESTRONE; HEK293 CELLS; HUMANS; ORGANIC ANION TRANSPORTERS;

EID: 84863382348     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2011.623796     Document Type: Article

References (57)

1. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H. (1999). Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 274:17159-17163.
2. Ahlin G, Hilgendorf C, Karlsson J, Szigyarto CA, Uhlen M, Artursson P. (2009). Endogenous gene and protein expression of drugtransporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos 37:2275-2283.
3. Braga F, Ayres-Saraiva D, Gattass CR, Capella MA. (2007). Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy. Cancer Lett 248:147-152.
4. Chen C, Zhou J, Ji C. (2010). Quercetin: a potential drug to reverse multidrug resistance. Life Sci 87:333-338.
5. Chen X, Cui L, Duan X, Ma B, Zhong D. (2006). Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metab Dispos 34:1345-1352. (Pubitemid 44079875)
6. Cui Q, Tashiro S, Onodera S, Ikejima T. (2006). Augmentation of oridonin-induced apoptosis observed with reduced autophagy. J Pharmacol Sci 101:230-239. (Pubitemid 44114317)
7. Fan L, Zhang W, Guo D, Tan ZR, Xu P, Li Q, Liu YZ, Zhang L, He TY, Hu DL, Wang D, Zhou HH. (2008). The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Ther 83:471-476. (Pubitemid 351272636)
8. Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M. (2010). (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 17:356-362.
9. Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J, Kerr DJ. (1996). Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2:659-668.
10. Fuchikami H, Satoh H, Tsujimoto M, Ohdo S, Ohtani H, Sawada Y. (2006). Effects of herbal extracts on the function of human organic aniontransporting polypeptide OATP-B. Drug Metab Dispos 34:577-582.
11. Genovese T, Menegazzi M, Mazzon E, Crisafulli C, Di Paola R, Dal Bosco M, Zou Z, Suzuki H, Cuzzocrea S. (2009). Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice. Shock 31:367-375.
12. Gui C, Obaidat A, Chaguturu R, Hagenbuch B. (2010). Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics 4:1-8.
13. Hagenbuch B, Meier PJ. (2003). The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1-18. (Pubitemid 36044060)
14. He SM, Chan E, Zhou SF. (2011). ADME properties of herbal medicines in humans: evidence, challenges and strategies. Curr Pharm Des 17:357-407.
15. Hong Byun E, Fujimura Y, Yamada K, Tachibana H. (2010). TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor. J Immunol 185:33-45.
16. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. (2004). Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2:2138-2145. (Pubitemid 40185773)
17. Ismair MG, Stanca C, Ha HR, Renner EL, Meier PJ, Kullak-Ublick GA. (2003). Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatol Res 26:343-347. (Pubitemid 37184525)
18. Iwai M, Suzuki H, Ieiri I, Otsubo K, Sugiyama Y. (2004). Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C). Pharmacogenetics 14:749-757. (Pubitemid 39552790)
19. Izzo AA, Ernst E. (2009). Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69:1777-1798.
20. Kim RB. (2003). Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur J Clin Invest 33 Suppl 2:1-5.
21. Kitamura A, Imai S, Yabuki M, Komuro S. (2007). The new acyl-CoA cholesterol acyltransferase inhibitor SMP-797 does not interact with statins via OATP1B1 in human cryopreserved hepatocytes and oocytes expressing systems. Biopharm Drug Dispos 28:517-525. (Pubitemid 351200990)
22. Klaassen CD, Aleksunes LM. (2010). Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1-96.
23. Konig J, Cui Y, Nies AT, Keppler D. (2000). A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol 278:G156-G164. (Pubitemid 30108080)
24. Liu H, Wei W, Sun WY, Li X. (2009). Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J Ethnopharmacol 122:502-508.
25. Liu J, Liu Y, Madhu C, Klaassen CD. (1993). Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice. J Pharmacol Exp Ther 266:1607-1613. (Pubitemid 24175811)
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
27. Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, Konig J, Fromm MF, Glaeser H. (2010). Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol 80:1746-1753.
28. Nabekura T, Yamaki T, Hiroi T, Ueno K, Kitagawa S. (2010). Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. Pharmacol Res 61:259-263.
29. Najar IA, Sachin BS, Sharma SC, Satti NK, Suri KA, Johri RK. (2010). Modulation of P-glycoprotein ATPase activity by some phytoconstituents. Phytother Res 24:454-458.
30. Niemi M, Pasanen MK, Neuvonen PJ. (2011). Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 63:157-181.
31. Novotny L, Vachalkova A, Biggs D. (2001). Ursolic acid: an antitumorigenic and chemopreventive activity. Minireview. Neoplasma 48:241-246. (Pubitemid 32802432)
32. Peralta EA, Murphy LL, Minnis J, Louis S, Dunnington GL. (2009). American Ginseng inhibits induced COX-2 and NFKB activation in breast cancer cells. J Surg Res 157:261-267.
33. Pick A, Muller H, Mayer R, Haenisch B, Pajeva IK, Weigt M, Bonisch H, Muller CE, Wiese M. (2011). Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). Bioorg Med Chem 19:2090-2102.
34. Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J. (2001). A population physiologically based pharmacokinetic/ pharmacodynamic model for the inhibition of 11-betahydroxysteroid dehydrogenase activity by glycyrrhetic acid. Toxicol Appl Pharmacol 170:46-55. (Pubitemid 32066386)
35. Roth M, Timmermann BN, Hagenbuch B. (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 39:920-926.
36. Saxena A, Tripathi KP, Roy S, Khan F, Sharma A. (2008). Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450. Bioinformation 3:198-204.
37. Smith NF, Acharya MR, Desai N, Figg WD, Sparreboom A. (2005). Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer Biol Ther 4:815-818.
38. Soars MG, Webborn PJ, Riley RJ. (2009). Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. Mol Pharm 6:1662-1677.
39. Song M, Hang TJ, Wang Y, Jiang L, Wu XL, Zhang Z, Shen J, Zhang Y. (2006). Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J Pharm Biomed Anal 40:190-196. (Pubitemid 43061237)
40. Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, Tsuji A. (2001). Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res 18:1262-1269. (Pubitemid 32846318)
41. Theoharides TC, Bielory L. (2004). Mast cells and mast cell mediators as targets of dietary supplements. Ann Allergy Asthma Immunol 93:S24-S34. (Pubitemid 39128483)
42. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, Pineau B, Weber P. (2003). A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 31:88-101. (Pubitemid 36553307)
43. Ullmann U, Haller J, Decourt JD, Girault J, Spitzer V, Weber P. (2004). Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers. Int J Vitam Nutr Res 74:269-278. (Pubitemid 39421008)
44. van Rossum TG, Vulto AG, Hop WC, Schalm SW. (1999). Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. Clin Ther 21:2080-2090. (Pubitemid 30043923)
45. van Zanden JJ, Wortelboer HM, Bijlsma S, Punt A, Usta M, Bladeren PJ, Rietjens IM, Cnubben NH. (2005). Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 69:699-708.
46. van Zanden JJ, van der Woude H, Vaessen J, Usta M, Wortelboer HM, Cnubben NH, Rietjens IM. (2007). The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 74:345-351. (Pubitemid 46890811)
47. Wang SJ, Gao WY, Chen HX, Xiao PG. (2005). New starches from Fritillaria species medicinal plants. Carbohydr polym 86:1365-1370.
48. Wang X, Wolkoff AW, Morris ME. (2005). Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos 33:1666-1672. (Pubitemid 41539965)
49. Wei SM, Yan ZZ, Zhou J. (2011). Protective effect of rutin on testicular ischemia-reperfusion injury. J Pediatr Surg 46:1419-1424.
50. Williamson G, Manach C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81:243S-255S.
51. Wong CC, Botting NP, Orfila C, Al-Maharik N, Williamson G. (2011). Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol 81:942-949.
52. Wong IL, Chan KF, Tsang KH, Lam CY, Zhao Y, Chan TH, Chow LM. (2009). Modulation of multidrug resistance protein 1 (MRP1/ ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. J Med Chem 52:5311-5322.
53. Yamamura Y, Kawakami J, Santa T, Kotaki H, Uchino K, Sawada Y, Tanaka N, Iga T. (1992). Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method. J Pharm Sci 81:1042-1046. (Pubitemid 23006873)
54. Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF. (2006). Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des 12:4649-4664. (Pubitemid 44835152)
55. Yulan S, Fang F. (2006). Sensitive liquid chromatography-tandem mass spectrometry method for the determination of scutellarin in human plasma: Application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 830:1-5. (Pubitemid 41831380)
56. Zhao YL, Zhou GD, Yang HB, Wang JB, Shan LM, Li RS, Xiao XH. (2011). Rhein protects against acetaminophen-induced hepatic and renal toxicity. Food Chem Toxicol 49:1705-1710.
57. Zhou S, Lim LY, Chowbay B. (2004). Herbal modulation of P-glycoprotein. Drug Metab Rev 36:57-104. (Pubitemid 38387835)